Immunovant, Inc.
(NASDAQ : IMVT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Finance » Financial Conglomerates
symbolcompany%chnglast%shortavg$volume
CCitigroup, Inc. 0.40%50.551.0%$1601.45m
AXPAmerican Express Co. 0.29%94.321.7%$561.64m
PRUPrudential Financial, Inc. 0.58%59.271.4%$235.79m
SHLLTortoise Acquisition Corp. 7.23%27.000.0%$215.79m
EQHEquitable Holdings, Inc. 0.85%19.020.0%$83.00m
FMCIForum Merger Ii Corp. 0.41%17.050.0%$76.70m
CNNECannae Holdings, Inc. -0.83%40.510.0%$67.72m
INGING Groep NV 3.33%7.130.2%$52.59m
LCALandcadia Holdings II, Inc. 0.70%14.450.0%$36.72m
CCHCollier Creek Holdings -1.10%13.550.0%$29.89m
GRAFGraf Industrial Corp. 48.66%20.590.0%$25.79m
IMVTImmunovant, Inc. 0.94%23.670.0%$16.86m
OPESOpes Acquisition Corp. -0.80%14.980.0%$16.44m
RIOTRiot Blockchain, Inc. -2.14%2.290.0%$11.57m
COHNCohen & Co., Inc. -1.22%9.700.0%$11.09m

Company Profile

Immunovant, Inc. is a clinical-stage biopharmaceutical company. It focuses on enabling normal lives for patients with autoimmune diseases. The company was founded in 2018 and is headquartered in New York, NY.